50-18-0

Cyclophosphamide is an alkylating agent type of anti-tumor drug, and its main target is DNA. Cyclophosphamide inhibits the proliferation of tumor cells by undergoing alkylation reactions with DNA, interfering with the replication and transcription processes of DNA.

Cyclophosphamide-D8 (Standard) is a reference standard of Cyclophosphamide-D8 intended for quantitative analysis, quality control, and related biochemical research applications. Cyclophosphamide-d8 is a deuterated compound of Cyclophosphamide. Cyclophosphamide has a CAS number of 50-18-0. Cyclophosphamide is an alkylating agent used in the treatment of several forms of cancer including leukemias, lymphomas and breast cancer.

Cyclophosphamide hydrate (Standard) is a reference standard for research and analysis in studies involving Cyclophosphamide hydrate. Cyclophosphamide hydrate is a synthetic alkylating agent structurally related to nitrogen mustards, with antitumor and immunosuppressive activities. It is widely used in the treatment of various cancers and is also commonly employed to induce animal models of premature ovarian failure, myelosuppression, cystitis, and myocarditis.

Cyclophosphamide-D4 is a deuterated compound of Cyclophosphamide. Cyclophosphamide (T0707L) has a CAS number of 50-18-0. Cyclophosphamide (T0707L) is an alkylating agent used in the treatment of several forms of cancer including leukemias, lymphomas and breast cancer.

Cyclophosphamide-D8 is a deuterated compound of Cyclophosphamide. Cyclophosphamide (T0707L) has a CAS number of 50-18-0. Cyclophosphamide (T0707L) is an alkylating agent used in the treatment of several forms of cancer including leukemias, lymphomas and breast cancer.

Cyclophosphamide hydrate is a synthetic alkylating agent structurally related to nitrogen mustards, with antitumor and immunosuppressive activities. It is widely used in the treatment of various cancers and is also commonly employed to induce animal models of premature ovarian failure, myelosuppression, cystitis, and myocarditis.